Another study by Li and colleagues16 showed a possible link between endocrine treatment and thromboembolic disease, in which they noted that the prevention of experimental arterial thrombosis by the use of androgens at physiological concentrations is mediated by the androgen receptor through modulation of platelet activation. The gene discussed is AR; the disease is Thromboembolism.